SPDR SP PHARMACEUTICALS ETF: (XPH)
(Delayed Data from AMEX) As of Sep 27, 2016 03:59 PM ET
$46.19 USD
+0.51 (1.12%)
Volume: 32,382
Zacks ETF Rank [?]: 2 - Buy 2
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Quote Details
| Previous Close | 45.68 |
| Open | 46.62 |
| Bid | 45.92 |
| Ask | 46.45 |
| Day Low-High | 45.64-46.19 |
| 52wk Low-High | 37.31-55.69 |
| Volume | 32,382 |
| NAV (month end) | 44.88 |
| Premium (+)/Discount (-) (month end) | +0.80 |
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
| Zacks Rank | Definition |
|---|---|
| 1 | Strong Buy |
| 2 | Buy |
| 3 | Hold |
| 4 | Sell |
| 5 | Strong Sell |
See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs
ETF Expense Ratio
| Expense Ratio | 0.35% |
| Dividend (Yield) | $0.23 (0.48%) |
| Issuer | STATE STREET GLOBAL ADVISORS |
Benchmark for XPH
SP PHARMACEUTICALS SELECT INDUSTRY INDEX
The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.
Fund Summary for XPH
SPDR SP PHARMACEUTICALS ETF
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.